Terumo (OTCMKTS:TRUMY) Shares Pass Below 50-Day Moving Average - Time to Sell?

Key Points

• Terumo Corp. stock has fallen below its fifty-day moving average of $17.62, closing at $17.21 during trading.
• The company's quarterly earnings report revealed $0.20 earnings per share, exceeding projections, but revenue of $1.76 billion fell short of expectations of $1.80 billion.
• With a market cap of $25.48 billion and a debt-to-equity ratio of only 0.07, Terumo demonstrates stable financial health relative to its industry.

Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $17.62 and traded as low as $17.05. Terumo shares last traded at $17.21, with a volume of 94,049 shares traded.

Terumo Price Performance

The company has a quick ratio of 1.53, a current ratio of 2.64 and a debt-to-equity ratio of 0.07. The firm's 50 day simple moving average is $17.62 and its 200 day simple moving average is $18.17. The company has a market capitalization of $24.58 billion, a PE ratio of 29.13 and a beta of 0.79.

Terumo (OTCMKTS:TRUMY - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.17 by $0.03. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.80 billion. Terumo had a net margin of 12.09% and a return on equity of 9.19%.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.